Expression of epithelial membrane protein‐2 is associated with endometrial adenocarcinoma of unfavorable outcome

Abstract

EMP2 expression is a feature of some prognostically unfavorable endometrial cancers. Its utility for clinical decision making and its biologic role in endometrial cancer deserves further study in a larger series of patients.